Royalty Pharma plc

NASDAQ:RPRX

32.77 (USD) • At close March 14, 2025
Bedrijfsnaam Royalty Pharma plc
Symbool RPRX
Munteenheid USD
Prijs 32.77
Beurswaarde 14,200,060,250
Dividendpercentage 2.89%
52-weken bereik 24.05 - 34.2
Industrie Biotechnology
Sector Healthcare
CEO Mr. Pablo Gerardo Legorreta
Website https://www.royaltypharma.com

An error occurred while fetching data.

Over Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research

Vergelijkbare Aandelen

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

70.69 USD

Biogen Inc. logo

Biogen Inc.

BIIB

139.44 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

166.2 USD

Hologic, Inc. logo

Hologic, Inc.

HOLX

60.71 USD

ICON Public Limited Company logo

ICON Public Limited Company

ICLR

184.58 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)